Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
Conclusion:
This study will explore the effectiveness and safety of DPP-4 inhibitors in the treatment of COVID-19 patients with diabetes. It will provide evidence-based medical evidence for DPP-4 inhibitors in the treatment of diabetes with COVID-19.
Registration number:
INPLASY202090015.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Clinical Trials | Conferences | COVID-19 | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Infectious Diseases | Insulin | Internal Medicine | Science | Study